Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Alpha2-adrenergic agonists for the management of opioid withdrawal.

Gowing L, Farrell MF, Ali R, White JM.

Cochrane Database Syst Rev. 2014 Mar 31;3:CD002024. doi: 10.1002/14651858.CD002024.pub4.

PMID:
24683051
[PubMed - in process]
2.

Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy.

Hirota T, Schwartz S, Correll CU.

J Am Acad Child Adolesc Psychiatry. 2014 Feb;53(2):153-73. doi: 10.1016/j.jaac.2013.11.009. Epub 2013 Dec 6.

PMID:
24472251
[PubMed - in process]
3.

Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology.

Sikirica V, Findling RL, Signorovitch J, Erder MH, Dammerman R, Hodgkins P, Lu M, Xie J, Wu EQ.

CNS Drugs. 2013 Nov;27(11):943-53. doi: 10.1007/s40263-013-0102-x.

PMID:
23975660
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.

Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J; European ADHD Guidelines Group.

J Child Psychol Psychiatry. 2013 Mar;54(3):227-46. doi: 10.1111/jcpp.12036. Epub 2013 Jan 7. Review.

PMID:
23294014
[PubMed - indexed for MEDLINE]
5.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

PMID:
23206211
[PubMed - indexed for MEDLINE]
Free Article
6.

Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.

Wu EQ, Hodgkins P, Ben-Hamadi R, Setyawan J, Xie J, Sikirica V, Du EX, Yan SY, Erder MH.

CNS Drugs. 2012 Jul 1;26(7):581-600. doi: 10.2165/11633900-000000000-00000. Review.

PMID:
22712698
[PubMed - indexed for MEDLINE]
7.

Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder: Final Update 4 Report [Internet].

McDonagh MS, Peterson K, Thakurta S, Low A.

Portland (OR): Oregon Health & Science University; 2011 Dec.

PMID:
22420008
[PubMed]
Books & Documents
8.

Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.

Duong S, Chung K, Wigal SB.

Expert Opin Drug Metab Toxicol. 2012 May;8(5):543-52. doi: 10.1517/17425255.2012.671295. Epub 2012 Mar 13. Review.

PMID:
22413882
[PubMed - indexed for MEDLINE]
9.

Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy.

Pringsheim T, Doja A, Gorman D, McKinlay D, Day L, Billinghurst L, Carroll A, Dion Y, Luscombe S, Steeves T, Sandor P.

Can J Psychiatry. 2012 Mar;57(3):133-43. Review.

PMID:
22397999
[PubMed - indexed for MEDLINE]
10.

Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults.

Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD007813. doi: 10.1002/14651858.CD007813.pub2. Review.

PMID:
21678370
[PubMed - indexed for MEDLINE]
11.

Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.

Pringsheim T, Steeves T.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD007990. doi: 10.1002/14651858.CD007990.pub2. Review.

PMID:
21491404
[PubMed - indexed for MEDLINE]
12.

Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder: Final Report Update 3 [Internet].

McDonagh MS, Christensen V, Peterson K, Thakurta S.

Portland (OR): Oregon Health & Science University; 2009 Oct.

PMID:
21089242
[PubMed]
Books & Documents
13.

Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.

Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF.

J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):884-93. doi: 10.1097/CHI.0b013e3181b26e9f.

PMID:
19625978
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Once-daily treatment of ADHD with guanfacine: patient implications.

Strange BC.

Neuropsychiatr Dis Treat. 2008 Jun;4(3):499-506.

PMID:
18830439
[PubMed]
Free PMC Article
15.

Alpha2 adrenergic agonists for the management of opioid withdrawal.

Gowing L, Farrell M, Ali R, White J.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002024. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD002024.

PMID:
15495025
[PubMed - indexed for MEDLINE]
16.

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.

Biederman J, Spencer T, Wilens T.

Int J Neuropsychopharmacol. 2004 Mar;7(1):77-97. Epub 2004 Jan 21. Review.

PMID:
14733627
[PubMed - indexed for MEDLINE]
17.

Alpha2 adrenergic agonists for the management of opioid withdrawal.

Gowing L, Farrell M, Ali R, White J.

Cochrane Database Syst Rev. 2003;(2):CD002024. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD002024.

PMID:
12804419
[PubMed - indexed for MEDLINE]
18.

Alpha2 adrenergic agonists for the management of opioid withdrawal.

Gowing L, Farrell M, Ali R, White J.

Cochrane Database Syst Rev. 2001;(1):CD002024. Review. Update in: Cochrane Database Syst Rev. 2003;(2):CD002024.

PMID:
11279747
[PubMed - indexed for MEDLINE]
19.

Anxiolytics, adrenergic agents, and naltrexone.

Riddle MA, Bernstein GA, Cook EH, Leonard HL, March JS, Swanson JM.

J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):546-56. Review.

PMID:
10230186
[PubMed - indexed for MEDLINE]
20.

Pharmacologic management of Alzheimer disease, Part II: Antioxidants, antihypertensives, and ergoloid derivatives.

Flynn BL, Ranno AE.

Ann Pharmacother. 1999 Feb;33(2):188-97. Review.

PMID:
10084415
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk